NABIDIOLEX
DEAD

Serial Number

85380134

Owner

GW Research Limited

Attorney

Anessa Owen Kramer

Filing Date

Jul 25, 2011

Add to watchlist:

No watchlists yet
View on USPTO

NABIDIOLEX Trademark

Serial Number: 85380134 • Registration: 4366678

NABIDIOLEX is a trademark filed by GW Research Limited on July 25, 2011. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

GW Research Limited (77 trademarks)

Sovereign House,

Entity Type: 98

GW Pharma Limited (40 trademarks)

Sovereign House, Histon

Entity Type: 03

Trademark Details

Filing Date

July 25, 2011

Registration Date

July 16, 2013

Published for Opposition

February 19, 2013

Cancellation Date

February 21, 2020

Goods & Services

Pharmaceutical and veterinary preparations, namely, herbs, herbal extracts, formulas containing herbal extracts, medicinal oils and pure extracts of medicinal plants and herbs, for use in the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; pharmaceutical and veterinary preparations for the treatment of pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases and metabolic disorders; herbs for medicinal purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes

Filing History

CANCELLED SEC. 8 (6-YR)
Feb 21, 2020 C8..
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 25, 2018 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 16, 2018 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 12, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 12, 2017 COAR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 29, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 29, 2017 REAP
REGISTERED-PRINCIPAL REGISTER
Jul 16, 2013 R.PR
1(B) BASIS DELETED; PROCEED TO REGISTRATION
Jun 6, 2013 DP1B
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 6, 2013 AITU
NOTICE OF ALLOWANCE CANCELLED
May 14, 2013 IUCN
TEAS DELETE 1(B) BASIS RECEIVED
May 14, 2013 D1BR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 16, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 19, 2013 NPUB
PUBLISHED FOR OPPOSITION
Feb 19, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 30, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 11, 2013 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 11, 2013 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 8, 2013 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 8, 2013 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 8, 2013 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 9, 2012 GNRN
NON-FINAL ACTION E-MAILED
Jul 9, 2012 GNRT
NON-FINAL ACTION WRITTEN
Jul 9, 2012 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 6, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 6, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 29, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 30, 2011 GNRN
NON-FINAL ACTION E-MAILED
Nov 30, 2011 GNRT
NON-FINAL ACTION WRITTEN
Nov 30, 2011 CNRT
ASSIGNED TO EXAMINER
Nov 18, 2011 DOCK
ASSIGNED TO EXAMINER
Nov 15, 2011 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Aug 25, 2011 AMPX
ASSIGNED TO LIE
Aug 15, 2011 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 2, 2011 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2011 NWOS
NEW APPLICATION ENTERED
Jul 28, 2011 NWAP